1558 — Yichang Hec Changjiang Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSuper Stock

Market Cap
HK$11.44bn
Enterprise Value
HK$12.43bn
Revenue
CNY6.29bn

Annual balance sheet for Yichang Hec Changjiang Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,779	2,045	1,131	1,214	1,693
Net Total Accounts Receivable
Net Total Receivables	2,345	600	547	1,037	2,113
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5,331	3,264	2,057	5,014	6,053
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,130	3,026	3,281	3,705	3,740
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	9,912	9,561	10,542	11,890	12,744
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,312	4,161	1,238	4,941	4,332
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	5,504	4,670	4,733	6,005	4,809
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	4,409	4,891	5,808	5,885	7,936
Total Liabilities & Shareholders' Equity	9,912	9,561	10,542	11,890	12,744
Total Common Shares Outstanding